新型鼻塞持续气道正压治疗新生儿低氧血症疗效分析

目的回顾性的研究新型鼻塞持续气道正压(nCPAP)治疗新生儿严重低氧血症的疗效及安全性。方法以常规给氧无效的83例严重低氧血症患儿为研究对象,其中足月儿32例,早产儿51例。呼吸暂停33例,肺炎并呼吸衰竭(呼衰)21例,肺透明膜病19例,胎粪吸入综合征6例,新生儿湿肺4例。给予使用新型nCPAP治疗,观察治疗效果、并发症发生情况。结果给予nCPAP治疗后绝大多数患儿缺氧状态得到改善。治愈67例,16例效果不好转为气管插管行其他模式机械通气治疗。腹胀8例,心功能不全5例,鼻前庭皮肤部压迫伤2例,无一例发生气漏、慢性肺疾病和早产儿视网膜病。结论新型nCPAP治疗新生儿严重低氧血症操作方便,疗效满意,可以很好的控制温度和吸入氧的浓度,避免了因吸入纯氧、高浓度氧引起的视网膜病、慢性肺疾病等氧中毒性损伤。减少了气管插管的机会,降低了呼吸机相关性肺炎的发生率,相对比较安全。

Evaluating the curative effect of a new type nasal obstruction continuous positive airway pressure in neonatal hypoxemia

Objective:To retrospective investigate the curative effect and safety of a new type nasal obstruction continuous positive airway pressure in serious neonatal hypoxemia.Methods:83 newborns to trouble a serious hypoxemia after treating in common oxygen therapy,including 32 term infants and 51 preterm infants. 33 infants have apnea,21 infants have pneumonia symphyso-respiratory failure,19 infants have hyaline membrane disease,6 infants have meconium aspiration syndrome and 4 infants have wet lung of newborn. T...